Guangdong Jiaying Pharmaceutical Co Ltd 002198.SZ

Last Updated: May 15, 12:00 AM·SZSE

Guangdong Jiaying Pharmaceutical Co Ltd

Guangdong Jiaying Pharmaceutical Co Ltd. Stock Analysis 002198.SZ

China Health Care Small Cap
Guangdong Jiaying Pharmaceutical Co., Ltd. engages in the manufacture, sale, research and development of Chinese patent medicines. The company is headquartered in Changsha, Hunan. The company went IPO on 2007-12-18. The firm's products mainly involve orthopedic, throat, cold, heat-clearing, tonic and gastrointestinal Chinese patent medicines. The firm's products include Shuangliao Houfeng Powder, Shuangliao Houfeng Lozenges, Chongganling Tablets, Yinqiao Jiedu Granules, Juhong Tanke Granules, Jieguqili Tablets, Jieguqili Capsules, Xiaoyan Licholeretic Tablets, Jinju Wuhua Tea Granules, Zhuangyao Jianshen Pills, Guifu Lizhong Pills, and others. The firm mainly distributes its products within domestic market.
Read More
Lock image
crown-icon

Shariah Compliance Report

An extensive business and financial screening of the company which specifies why a stock is halal or haram!

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.